GAVIN HARPER: Open Payments
NPI 1457816282 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 40 payments from 13 companies in 2025. Trend: 2023 $496 · 2024 $847 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $263 |
| E.R. Squibb & Sons, L.L.C. | 4 | $188 |
| Novo Nordisk Inc | 3 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $114 |
| BridgeBio Pharma, Inc. | 1 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| PFIZER INC. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $19 |
Products named: REPATHA, LEQVIO, Attruby, Wegovy, CAMZYOS, JARDIANCE, Ozempic, ONPATTRO.
Industry payments across PA — which companies pay providers there.
